International Assets Investment Management LLC Raises Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

International Assets Investment Management LLC increased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 693.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 23,299 shares of the health services provider’s stock after purchasing an additional 20,361 shares during the quarter. International Assets Investment Management LLC’s holdings in Teladoc Health were worth $214,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of TDOC. Allspring Global Investments Holdings LLC increased its position in shares of Teladoc Health by 74.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after purchasing an additional 8,750 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Teladoc Health by 40.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 209,689 shares of the health services provider’s stock valued at $3,166,000 after acquiring an additional 60,780 shares during the last quarter. Janney Montgomery Scott LLC grew its position in Teladoc Health by 188.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock valued at $477,000 after acquiring an additional 20,651 shares during the last quarter. Oppenheimer & Co. Inc. grew its position in Teladoc Health by 105.9% in the 1st quarter. Oppenheimer & Co. Inc. now owns 24,425 shares of the health services provider’s stock valued at $369,000 after acquiring an additional 12,561 shares during the last quarter. Finally, Swiss National Bank grew its position in Teladoc Health by 0.6% in the 1st quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock valued at $4,936,000 after acquiring an additional 1,800 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Trading Up 3.0 %

Shares of NYSE TDOC opened at $9.42 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market capitalization of $1.62 billion, a P/E ratio of -1.62 and a beta of 0.90. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $22.54. The business has a fifty day moving average price of $8.55 and a 200 day moving average price of $9.58.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Equities research analysts expect that Teladoc Health, Inc. will post -1.19 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on TDOC. Barclays upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Piper Sandler cut their price objective on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Royal Bank of Canada upped their price objective on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Finally, Oppenheimer dropped their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating on the stock in a research report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $11.97.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, Director Thomas Mckinley purchased 4,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was bought at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares in the company, valued at $300,502.13. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Teladoc Health news, COO Michael Willem Waters sold 4,218 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now directly owns 78,309 shares in the company, valued at approximately $560,692.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Thomas Mckinley acquired 4,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the acquisition, the director now directly owns 39,077 shares of the company’s stock, valued at approximately $300,502.13. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 20,051 shares of company stock worth $143,565. 0.95% of the stock is owned by insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.